Sept 21 (Reuters) – Kadmon Holdings Inc :
Source text for Eikon:
Further company coverage:
The post BRIEF-Kadmon initiates placebo-controlled phase 2 clinical trial evaluating KD025 in Psoriasis appeared first on NASDAQ.
Forex – financial instrument.Forex news
Sept 21 (Reuters) – Kadmon Holdings Inc :
Source text for Eikon:
Further company coverage:
The post BRIEF-Kadmon initiates placebo-controlled phase 2 clinical trial evaluating KD025 in Psoriasis appeared first on NASDAQ.